Reducing cholinergic constriction: the major reversible mechanism in COPD
The airway narrowing in chronic obstructive pulmonary disease (COPD) has often been misunderstood as being irreversible. However, a large proportion of patients with COPD do respond to bronchodilator agents with significant changes in lung function. Unlike in asthma, abnormalities in airway smooth m...
Main Author: | V. Brusasco |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2006-12-01
|
Series: | European Respiratory Review |
Subjects: | |
Online Access: | http://err.ersjournals.com/cgi/content/full/15/99/32 |
Similar Items
-
Bronchodilator treatment of stable COPD: long-acting anticholinergics
by: W. Vincken
Published: (2005-09-01) -
Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations
by: R. Rodríguez-Roisin
Published: (2006-12-01) -
The Impact of Bronchodilator Therapy on Systolic Heart Failure with Concomitant Mild to Moderate COPD
by: Mahoto Kato, et al.
Published: (2017-12-01) -
Effects of indacaterol versus tiotropium on exercise tolerance in patients with moderate COPD: a pilot randomized crossover study
by: Danilo Cortozi Berton, et al. -
Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
by: Anthony D’Urzo, et al.
Published: (2019-03-01)